Patents Assigned to miCure Therapeutics Ltd.
  • MODIFIED MIR-135, CONJUGATED FORM THEREOF, AND USES OF SAME
    Publication number: 20240026357
    Abstract: A composition of matter comprising a synthetic miR-135 molecule comprising a nucleic acid sequence of a miR-135b as set forth in SEQ ID NO: 37, and a complementary strand as set forth in SEQ ID NO: 40 is disclosed. A conjugate comprising a composition of matter comprising a synthetic miR-135 molecule and a cell-targeting moiety is also disclosed.
    Type: Application
    Filed: July 14, 2023
    Publication date: January 25, 2024
    Applicants: Yeda Research and Development Co. Ltd., miCure Therapeutics Ltd.
    Inventors: Alon CHEN, Sharon MANASHIROV, Andres Pablo MONTEFELTRO